Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3)
Brazil · Delayed Price · Currency is BRL 24.54
-0.05 (-0.20%)
At close: Jan 30, 2026
BVMF:OFSA3 Revenue
Ouro Fino Saúde Animal Participações had revenue of 356.51M BRL in the quarter ending September 30, 2025, with 26.17% growth. This brings the company's revenue in the last twelve months to 1.15B, up 20.15% year-over-year. In the year 2024, Ouro Fino Saúde Animal Participações had annual revenue of 1.02B with 8.64% growth.
Revenue (ttm)
1.15B
Revenue Growth
+20.15%
P/S Ratio
1.15
Revenue / Employee
1.09M
Employees
1,052
Market Cap
1.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.02B | 81.51M | 8.64% |
| Dec 31, 2023 | 943.28M | -97.83M | -9.40% |
| Dec 31, 2022 | 1.04B | 136.12M | 15.04% |
| Dec 31, 2021 | 904.99M | 174.88M | 23.95% |
| Dec 31, 2020 | 730.11M | 110.52M | 17.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Profarma Distribuidora de Produtos Farmacêuticos | 11.28B |
| Fleury | 8.07B |
| Hypera | 6.97B |
| Dimed S.A. Distribuidora de Medicamentos | 5.29B |
| Hospital Mater Dei | 2.10B |
| Blau Farmacêutica | 1.77B |
Ouro Fino Saúde Animal Participações News
- 1 year ago - Q3 2024 Ouro Fino Saude Animal Participacoes SA Earnings Call Transcript - GuruFocus